In-Vitro Analysis of Ethanol Extract of Saponaria Officinalis for Antiurolithiatic Activity

Abstract

The goal of the current study was to assess Saponaria officinalis ethanol extracts' in-vitro anti-urolithiatic effectiveness as a potential natural therapy to combat adverse effects brought on by the use of contemporary synthetic medications. S. officinalis extracted with ethanol was put to the test for its ability to treat urolithiasis utilizing in vitro studies (nucleation, aggregation assays). This extract was evaluated and contrasted with the reference medication cystone at increasing concentrations of 200, 400, 600, 800, and 1000μg/ml. The extract's ability to suppress the growth of calcium oxalate crystals in preformed forms was evaluated. The results of the S. officinalis extract on the nucleation assay were significant and showed considerable inhibition 64.2%±0.5 compared to standard cystone drug 67.7%±0.8 at 1000μg/ml concentration. Additionally, the ethanol extract of S. officinalis showed significant inhibition in the aggregation assay with a difference of 74.2%±0.08 compared to cystone 76.7%±0.09 at 1000μg/ml concentration. At a dose level of 1000μg/ml, the ethanol extract of S. officinalis possesses anti-urolithiatic potentials in vitro. It is possible to further exploit the ethanol extract of S. officinalis as a potential anti-urolithiasis medication.